These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6750877)

  • 1. Cyclosporin A and methotrexate in canine marrow transplantation: engraftment, graft-versus-host disease, and induction of intolerance.
    Deeg HJ; Storb R; Weiden PL; Raff RF; Sale GE; Atkinson K; Graham TC; Thomas ED
    Transplantation; 1982 Jul; 34(1):30-5. PubMed ID: 6750877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FK-506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated dog leukocyte antigen-nonidentical donors.
    Storb R; Raff RF; Appelbaum FR; Deeg HJ; Fitzsimmons W; Graham TC; Pepe M; Pettinger M; Sale G; van der Jagt R
    Transplantation; 1993 Oct; 56(4):800-7. PubMed ID: 7692635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined immunosuppression with cyclosporine and methotrexate in dogs given bone marrow grafts from DLA-haploidentical littermates.
    Deeg HJ; Storb R; Appelbaum FR; Kennedy MS; Graham TC; Thomas ED
    Transplantation; 1984 Jan; 37(1):62-5. PubMed ID: 6364490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marrow graft studies in dogs: factors influencing resistance to engraftment and graft-versus-host disease.
    Deeg HJ; Storb R; Thomas ED
    Surv Immunol Res; 1982; 1(2):148-54. PubMed ID: 6764839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of graft-versus-host disease by immunosuppressive agents after transplantation of DLA-nonidentical canine marrow.
    Storb R; Kolb HJ; Deeg HJ; Weiden PL; Appelbaum F; Graham TC; Thomas ED
    Bone Marrow Transplant; 1986 Dec; 1(2):167-77. PubMed ID: 3332131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific tolerance and immunocompetence in haploidentical, but not in completely allogeneic, canine chimeras treated with methotrexate and cyclosporine.
    Deeg HJ; Severns E; Raff RF; Sale GE; Storb R
    Transplantation; 1987 Nov; 44(5):621-32. PubMed ID: 2961110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.
    Storb R; Yu C; Wagner JL; Deeg HJ; Nash RA; Kiem HP; Leisenring W; Shulman H
    Blood; 1997 Apr; 89(8):3048-54. PubMed ID: 9108426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus (FK506) and methotrexate regimens to prevent graft-versus-host disease after unrelated dog leukocyte antigen (DLA) nonidentical marrow transplantation.
    Yu C; Storb R; Deeg HJ; Graham TC; Scheuning FG; Huss R; Seidel K; Fitzsimmons WE
    Bone Marrow Transplant; 1996 Apr; 17(4):649-53. PubMed ID: 8722370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engraftment of DLA-nonidentical bone marrow facilitated by recipient treatment with anti-class II monoclonal antibody and methotrexate.
    Deeg HJ; Sale GE; Storb R; Graham TC; Schuening F; Appelbaum FR; Thomas ED
    Transplantation; 1987 Sep; 44(3):340-5. PubMed ID: 3307057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of acute graft-versus-host disease in the dog. An autopsy study of ninety-five dogs.
    Kolb H; Sale GE; Lerner KG; Storb R; Thomas ED
    Am J Pathol; 1979 Aug; 96(2):581-94. PubMed ID: 38670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Canine Model of Chronic Graft-versus-Host Disease.
    Graves SS; Rezvani A; Sale G; Stone D; Parker M; Rosinski S; Spector M; Swearingen B; Kean L; Storb R
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):420-427. PubMed ID: 28013013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engraftment of DLA-nonidentical unrelated canine marrow after high-dose fractionated total body irradiation.
    Deeg HJ; Storb R; Shulman HM; Weiden PL; Graham TC; Thomas ED
    Transplantation; 1982 Apr; 33(4):443-6. PubMed ID: 7041371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histoincompatible skin and marrow grafts in rabbits on cyclosporin A.
    Gratwohl A; Forster I; Speck B
    Transplantation; 1982 Apr; 33(4):361-4. PubMed ID: 7041361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoids fail to enhance the effect of FK506 and methotrexate in prevention of graft-versus-host disease after DLA-nonidentical, unrelated marrow transplantation.
    Yu C; Seidel K; Fitzsimmons WE; Sale G; Storb R
    Bone Marrow Transplant; 1997 Jul; 20(2):137-41. PubMed ID: 9244417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft-versus-host disease after marrow transplantation.
    Storb R
    Prog Clin Biol Res; 1986; 224():139-57. PubMed ID: 3540990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marrow grafts between DLA-identical and homozygous unrelated dogs: evidence for an additional locus involved in graft-versus-host disease.
    Storb R; Weiden PL; Graham TC; Lerner KG; Thomas ED
    Transplantation; 1977 Sep; 24(3):165-74. PubMed ID: 22945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion.
    Zorn J; Herber M; Schwamberger S; Panzer W; Adler H; Kolb HJ
    Exp Hematol; 2009 Aug; 37(8):998-1006. PubMed ID: 19446000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marrow transplant experience for children with severe aplastic anemia.
    Sanders JE; Storb R; Anasetti C; Deeg HJ; Doney K; Sullivan KM; Witherspoon RP; Hansen J
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):43-9. PubMed ID: 8311172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An anti-CD44 antibody does not enhance engraftment of DLA-identical marrow after low-dose total body irradiation.
    Sandmaier BM; Storb R; Liu Y; Santos EB; Bryant E; Schuening FG; Deeg HJ; Seidel K; Graham T
    Transpl Immunol; 1996 Dec; 4(4):271-4. PubMed ID: 8972556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic, toxicologic, and marrow transplantation studies in dogs given succinyl acetone.
    Raff RF; Storb R; Graham T; Fidler JM; Sale GE; Johnston B; Deeg HJ; Pepe M; Schuening F; Appelbaum FR
    Transplantation; 1992 Nov; 54(5):813-20. PubMed ID: 1440847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.